Lovesac (NASDAQ:LOVE) Stock, Quote.Headers.trade-ideas

Lovesac

The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.

LOVE

Equities

News

Markets

Movers

General

Lovesac&#39;s Q2 loss was narrower than expected, sales missed estimates, and the company updated its FY2025 guidance with a lower outlook.

Lovesac Reports Q2 Loss Narrower Than Expected, Updates FY2025 Guidance

xr:d:DAFlNs0AWQM:2,j:6886396588877453870,t:23060806

Intraday Update

Trading Ideas

BYRN

JBDI

LVWR

NTGR

SMMT

WOOF

Signet Jewelers Posts Better-Than-Expected Earnings, Joins NETGEAR, Lovesac And Other Big Stocks Moving Higher On Thursday

Stock market analysts

Earnings

Price Target

Pre-Market Outlook

Analyst Ratings

Top Wall Street Forecasters Revamp Lovesac Price Expectations Ahead Of Q2 Earnings

The Lovesac Co

Love & Health Limited

Love & Health Ltd

LOVE GROUP GLOBAL LTD by LOVE GROUP GLOBAL LTD.

Love Group Global Ltd

LOVE HEMP GROUP PLC by LOVE HEMP GROUP PLC

Love Hemp Group PLC

Friday, Sanofi SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) released data from the HERCULES phase 3 study of tolebrutinib for non-relapsing secondary progressive multiple sclerosis (nrSPMS).
The <a target="_blank" href="https://www.sanofi.com/en/media-room/press-releases/2024/2024-09-20-09-30-00-2949552" rel="noreferrer noopener">data</a> demonstrated that tolebrutinib delayed the time to onset of 6-month confirmed disability progression (CDP) by 31% compared to placebo (HR 0.69; p=0.0026).
Further analysis of secondary endpoints demonstrated that the number of participants who experienced confirmed disability improvement increased by nearly two-fold, 10% with tolebrutinib compared to 5% with placebo (HR 1.88; nominal p=0.021).
Based on the preliminary analysis of the HERCULES study, there was a slight increase in tolebrutinib-treated patients of some adverse events.
Liver enzyme elevations were observed in 4.1% of participants receiving tolebrutinib compared with 1.6% in the placebo group, a side effect also reported with other BTK inhibitors in MS.
All but one case of liver enzyme elevations were resolved without further medical intervention.
Earlier this month, Sanofi released results from the GEMINI 1 and 2 phase 3 studies of tolebrutinib that did not meet the primary endpoint of reducing annualized relapse rate (ARR) compared to Aubagio (teriflunomide) in relapsing <a target="_blank" href="https://www.benzinga.com/general/biotech/24/09/40684403/sanofi-still-bets-on-multiple-sclerosis-med-tolebrutinib-despite-the-investigational-drug-fell-sh" rel="noreferrer noopener">forms of multiple sclerosis</a>.
However, analysis of the key secondary endpoint of pooled 6-month confirmed disability worsening (CDW) data showed a considerable delay in time to onset, which supports the CDP data observed in HERCULES.
In preliminary analysis of the GEMINI 1 and 2 pooled safety data, adverse events observed between the tolebrutinib and Aubagio arms were generally balanced. Liver enzyme elevations were observed in 5.6% of participants receiving tolebrutinib compared with 6.3% of participants receiving Aubagio.
Study results will form the basis for future discussions with global regulatory authorities, with submissions starting in H2 2024.
The PERSEUS phase 3 study in primary progressive MS is ongoing, with study results anticipated in H2 2025.
Price Action: SNY stock is down 0.53% at $57.95 during the premarket session at last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/09/40956171/european-drug-agency-supports-novo-nordisks-blockbuster-weight-loss-drug-wegovy-for-obesity-relat" target="_blank" rel="noreferrer noopener">European Drug Agency Supports Novo Nordisk&#8217;s Blockbuster Weight-Loss Drug Wegovy For Obesity-Related Heart Failure</a>.</li>
</ul>
Image by HJBC via Shutterstock

Biotech

Large Cap

Health Care

Sanofi's Tolebrutinib Delays Disability Progression In Patients With Multiple Sclerosis, Data Shows

Jeff Bezos, Oprah Winfrey and Sandra Bullock top the list of celebrities with the highest number of properties in the U.S., each owning seven properties.
An analysis by real estate investment company SoCal homebuyers reveals that celebrity real estate portfolios are reaching new heights amid a growing trend of wealth diversification through property ownership.
Don't Miss:
<ul>
<li>Elon Musk&#8217;s secret mansion in Austin revealed through court filings.<a href="https://www.benzinga.com/money/elon-musk-secret-mansion-austin-nada"> Here&#8217;s how to invest in the city&#8217;s growth before prices go back up.</a></li>
<li>A billion-dollar investment strategy with minimums as low as $10 —<a href="https://www.benzinga.com/money/fundrise-flagship-fund"> you can become part of the next big real estate boom today.</a></li>
</ul>
In terms of value, SoCal homebuyers found that Bezos's portfolio is worth the most at $458.9 million, followed by Jay-Z and Beyoncé, who own five properties worth a total of $315.5 million.
"These <a href="https://www.benzinga.com/real-estate/24/09/40901909/j-los-home-hunt-a-surprising-twist-as-she-considers-property-neighboring-ex-boyfriend-diddy-combs">celebrity portfolios</a> offer valuable lessons for all investors," SoCal homebuyers Co-Founder Doug Van Soest said. "While the scale is impressive, the underlying principles are universal. Diversification, location selection and long-term value appreciation are key, whether you're investing millions or starting with a single property."
Trending: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." <a href="https://www.benzinga.com/money/connect-invest-real-estate-notes">These high-yield real estate notes that pay 7.5% &#8211; 9% make earning passive income easier than ever.</a>
<h2 class="wp-block-heading">10 Celebrities With Highest Number Of Properties In U.S.</h2>
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Rank</td>
<td>Celebrity</td>
<td>Number of properties</td>
</tr>
<tr>
<td>1</td>
<td>Jeff Bezos</td>
<td>7</td>
</tr>
<tr>
<td>1</td>
<td>Oprah Winfrey</td>
<td>7</td>
</tr>
<tr>
<td>1</td>
<td>Sandra Bullock</td>
<td>7</td>
</tr>
<tr>
<td>4</td>
<td>Leonardo DiCaprio</td>
<td>6</td>
</tr>
<tr>
<td>4</td>
<td>Taylor Swift</td>
<td>6</td>
</tr>
<tr>
<td>6</td>
<td>George Lucas</td>
<td>5</td>
</tr>
<tr>
<td>6</td>
<td>Jay-Z and Beyoncé</td>
<td>5</td>
</tr>
<tr>
<td>6</td>
<td>Kim Kardashian</td>
<td>5</td>
</tr>
<tr>
<td>9</td>
<td>Kylie Jenner</td>
<td>4</td>
</tr>
<tr>
<td>9</td>
<td>Reese Witherspoon</td>
<td>4</td>
</tr>
</tbody>
</table>
</figure>
Source: SoCal homebuyers
Bezos's portfolio includes a $165 million estate in Beverly Hills, California and a $78 million Hawaii resident property, reflecting his penchant for luxury and privacy. The Beverly Hills mansion, formerly owned by media mogul David Geffen, is on nine acres and boasts multiple buildings, a tennis court and a nine-hole golf course.
Trending: Will the surge continue or decline on real estate prices?<a href="https://www.benzinga.com/money/realbricks"> People are finding out about risk-free real estate investing that lets you cash out whenever you want.</a>
<a href="https://www.benzinga.com/real-estate/24/07/40001374/from-bill-gates-to-oprah-winfrey-the-most-lavish-celebrity-homes-revealed">Winfrey</a>'s real estate investments range from a sprawling 66-acre estate in Montecito, California, to a ski home in Telluride, Colorado. Her California property, dubbed The Promised Land, features a 23,000-square-foot main house with many luxurious amenities. The Telluride ski house, valued at $14 million, offers mountain views and unique features like a 56-foot-long wine cellar.
Bullock's diverse real estate portfolio includes homes in New Orleans, Southern California and Austin, Texas. Her $2.7 million Victorian home in the Big Easy's Garden District showcases classic architectural details, while her lakefront home in Austin boasts modern design. Her Beverly Hills residence offers privacy in an exclusive gated community.
Trending: Oprah, Madonna and DiCaprio have turned to the alternative asset that is outperforming the S&amp;P 500<a href="https://www.benzinga.com/money/masterworks">. Discover the potential of this market before other investors.</a>
<h2 class="wp-block-heading">10 Celebrities With Highest-Value Property Portfolio In U.S.</h2>
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Rank</td>
<td>Celebrity</td>
<td>Total value paid for properties</td>
</tr>
<tr>
<td>1</td>
<td>Jeff Bezos</td>
<td>$458,900,000</td>
</tr>
<tr>
<td>2</td>
<td>Jay-Z and Beyoncé</td>
<td>$315,450,000</td>
</tr>
<tr>
<td>3</td>
<td>George Lucas</td>
<td>$196,100,000</td>
</tr>
<tr>
<td>4</td>
<td>Mark Zuckerberg</td>
<td>$166,000,000</td>
</tr>
<tr>
<td>5</td>
<td>Kim Kardashian</td>
<td>$115,100,000</td>
</tr>
<tr>
<td>6</td>
<td>Taylor Swift</td>
<td>$92,750,000</td>
</tr>
<tr>
<td>7</td>
<td>Ellen DeGeneres</td>
<td>$91,500,000</td>
</tr>
<tr>
<td>8</td>
<td>Oprah Winfrey</td>
<td>$84,415,000</td>
</tr>
<tr>
<td>9</td>
<td>Kylie Jenner</td>
<td>$66,750,000</td>
</tr>
<tr>
<td>10</td>
<td>Madonna</td>
<td>$61,300,000</td>
</tr>
</tbody>
</table>
</figure>
Source: SoCal homebuyers
"In our experience, successful real estate investment is about more than status – it's about making informed decisions based on market trends and potential for growth," Van Soest said. "Even in today's dynamic market, real estate remains a powerful tool for building and preserving wealth when approached strategically."
Read Next:
<ul>
<li>This billion-dollar fund has invested in the next big real estate boom,<a href="https://www.benzinga.com/money/fundrise-flagship-fund"> here's how you can join for $10.</a></li>
<li>Commercial real estate has historically outperformed the stock market, and<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a></li>
</ul>

Real Estate

Celebrity Property Portfolios Soar, With Bezos And Oprah Tied For The Top Spot

Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) shares are <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40954941/palantir-expands-maven-smart-system-aiml-capabilities-to-military-services" rel="noreferrer noopener">trading lower in the premarket session on Friday.</a>
The company announced a contract granted by the DEVCOM Army Research Laboratory (ARL) that broadens Maven Smart System access across military branches, including the Army, Air Force, Space Force, Navy, and U.S. Marine Corps.
This firm-fixed price contract totals up to $99.804 million over five years and streamlines the process for services to utilize the existing features of the Maven Smart System. Maven Smart System is part of the National Geospatial-Intelligence Agency&#8217;s Maven AI framework.
&#8220;To stay ahead of our adversaries, we must deliver software advantage at speed and at every level of the Department of Defense,&#8221; said Shannon Clark, Head of Defense Growth, Palantir.&nbsp;
Also Read:<a target="_blank" href="https://www.benzinga.com/news/24/09/40951997/palantir-co-founder-joe-lonsdale-backs-elon-musks-twitter-acquisition-saying-if-he-had-not-bought-it" rel="noreferrer noopener"> Palantir Co-Founder Joe Lonsdale Backs Elon Musk&#8217;s Twitter Acquisition, Saying If He Had Not Bought It Then &#8216;The Entire West Would Be At 10x The Threat&#8217;</a>
Under the latest development, Palantir&#8217;s platform will enhance AI-enabled battlespace awareness and support global integration, force management, logistics, and joint targeting workflows to improve military interoperability and readiness.
&#8220;This contract vehicle will allow every military department to tap into the innovation that the Office of Secretary of Defense and NGA have created through Maven to accelerate their own CJADC2 programs,&#8221; said Akash Jain, President of Palantir USG.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, PLTR stock has gained over 149% in the past year. Investors can gain exposure to the stock via&nbsp;REX AI Equity Premium Income ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIPI#NASDAQ">AIPI</a>) and&nbsp;Global X Funds Global X Defense Tech ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHLD#NYSE">SHLD</a>).
Price Action: PLTR shares are trading lower by 2.39% to $35.95 premarket at last check Friday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40946478/chinas-nio-says-40-of-its-store-managers-are-ex-tesla" target="_blank" rel="noreferrer noopener">China&#8217;s NIO Says 40% Of Its Store Managers Are Ex-Tesla</a></li>
</ul>

Contracts

AIPI

PLTR

SHLD

Palantir Wins Deal Worth Multi-Million Dollars To Expand Maven Smart System Across US Army, Air Force, Space Force & Navy

RBC Capital analyst Leonid Timashev maintains Edgewise Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWTX#NASDAQ">EWTX</a>) with a Outperform and raises the price target from $32 to $42.

EWTX

RBC Capital Maintains Outperform on Edgewise Therapeutics, Raises Price Target to $42

WIIM

NovaBay Pharmaceuticals shares are trading higher after the company announced it reached a definitive deal to sell its Avenova assets for $9.5 million.

B of A Securities analyst Benjamin Haynor maintains Viasat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSAT#NASDAQ">VSAT</a>) with a Buy and lowers the price target from $31 to $19.

VSAT

B of A Securities Maintains Buy on Viasat, Lowers Price Target to $19

<ul>
<li>NVDA</li>
<li>LUNR</li>
<li>MADE</li>
<li>WAY</li>
<li>TSLA</li>
<li>DJT</li>
<li>FDX</li>
<li>LOT</li>
<li>QQQ</li>
<li>AAPL</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

AAPL

LUNR

MADE

NVDA

TSLA

Top 10 Trending Stocks On WallStreetBets As Of September 20, 2024 (Via Swaggy Stocks)

On Wednesday, Eli Lilly And Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) has urged a federal appeals court to overturn a $183 million judgment stemming from accusations of defrauding Medicaid.
The case, initiated in 2014, alleges that Eli Lilly underreported drug prices to Medicaid, resulting in smaller rebates owed to the program.
Last week,&nbsp;Walgreens Boots Alliance&nbsp;Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) agreed to pay $106.8 million to settle allegations that it submitted false claims to government healthcare programs, violating the False Claims Act&nbsp;<a target="_blank" href="https://www.benzinga.com/news/large-cap/24/09/40881893/walgreens-agrees-to-106-8m-settlement-over-alleged-false-billing-claims" rel="noreferrer noopener">and state regulations</a>.
The U.S. pharma giant claims it is being wrongfully held liable despite adhering to its interpretation of Medicaid&#8217;s complex rebate requirements.
The claims also highlight that Eli Lilly failed to disclose price increases billed to distributors, which were not reflected in its Medicaid pricing reports.
Reuters noted that Eli Lilly started reporting price increases after a 2017 rule change, though the company claims it had previously informed regulators about its pricing practices without facing any objections.
In 2022, a U.S. District Judge rejected Eli Lilly&#8217;s motion for summary judgment, ruling that its price statements were misleading and allowing the case to proceed. In May 2023, a jury found Eli Lilly responsible for $61 million in damages, which were tripled to $183 million under the federal False Claims Act.
Most recently, Oak Street Health, a subsidiary of&nbsp;CVS Health&nbsp;Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>), agreed to settle for $60 million following allegations that it violated the <a target="_blank" href="https://www.benzinga.com/news/large-cap/24/09/40945496/cvs-subsidiary-oak-street-health-agrees-to-60m-settlement-in-medicare-kickback-violations" rel="noreferrer noopener">False Claims Act</a>.
The&nbsp;<a target="_blank" href="https://www.justice.gov/opa/pr/oak-street-health-agrees-pay-60m-resolve-alleged-false-claims-act-liability-paying-kickbacks" rel="noreferrer noopener">claims</a> involved paying kickbacks to third-party insurance agents to recruit seniors to its primary care clinics, a practice that led to false Medicare submissions.
The case has garnered attention from major business groups, including the U.S. Chamber of Commerce and Pharmaceutical Research and Manufacturers of America (PhRMA). These organizations argue that upholding the judgment would create uncertainty for regulated companies.
Price Action: LLY stock is trading higher by 1.45% to $928.28 premarket at the last check on Friday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40955083/holiday-opportunity-macys-plans-to-hire-31-500-seasonal-workers" target="_blank" rel="noreferrer noopener">Holiday Opportunity: Macy&#8217;s Plans To Hire 31,500 Seasonal Workers</a>.</li>
</ul>
Photo via Shutterstock

Legal

Eli Lilly Fights $183M Medicaid Fraud Judgment, Cites Reasonable Interpretation Of Medicaid Rules

Wells Fargo analyst Colin Langan upgrades Visteon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VC#NASDAQ">VC</a>) from Equal-Weight to Overweight and raises the price target from $115 to $122.

Upgrades

Wells Fargo Upgrades Visteon to Overweight, Raises Price Target to $122

Guidance

RLND

RoyaLand Sees Prelim FY24 Adj. Net Loss $(1.059M)

Morgan Stanley analyst Andrew Ruben maintains MercadoLibre (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>) with a Overweight and raises the price target from $2175 to $2500.

MELI

Morgan Stanley Maintains Overweight on MercadoLibre, Raises Price Target to $2500

ZONE

CleanCore Solutions shares are trading higher. The company reported full-year fiscal 2024 results.

Wells Fargo analyst Colin Langan downgrades Dana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAN#NYSE">DAN</a>) from Equal-Weight to Underweight and lowers the price target from $13 to $9.

Downgrades

Wells Fargo Downgrades Dana to Underweight, Lowers Price Target to $9

Constellation Energy Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) shares are trading higher after the company announced it signed a 20-year power purchase agreement with Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>).
The deal entails the launch of the Crane Clean Energy Center (CCEC) and the restart of Three Mile Island Unit 1, <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40954951/constellation-to-launch-crane-clean-energy-center-restoring-jobs-and-carbon-free-power-to-the-grid" rel="noreferrer noopener">which was closed five years ago.</a>
As per this agreement, Microsoft will source energy from the renewed plant to align its PJM data centers&#8217; power use with carbon-free energy, supporting its sustainability goals.
Unit 1 is next to TMI Unit 2, which has been shut down since 1979 and is being decommissioned by Energy Solutions. Unit 1 operates independently and was unaffected by the accident.
Constellation will also seek a license renewal to extend operations until at least 2054. The CCEC is expected to be operational by 2028.
Joe Dominguez, president and, CEO, Constellation said, &#8220;Powering industries critical to our nation&#8217;s global economic and technological competitiveness, including data centers, requires an abundance of energy that is carbon-free and reliable every hour of every day, and nuclear plants are the only energy sources that can consistently deliver on that promise.&#8221;
Constellation purchased TMI Unit 1, in 1999 and was retired for economic reasons in 2019. The plant will be renamed the Crane Clean Energy Center in honor of&nbsp;Chris Crane, who was CEO of Constellation&#8217;s former parent company.
Bobby Hollis, VP of Energy, Microsoft said, &#8220;This agreement is a major milestone in Microsoft&#8217;s efforts to help decarbonize the grid in support of our commitment to become carbon negative. Microsoft continues to collaborate with energy providers to develop carbon-free energy sources to help meet the grids&#8217; capacity and reliability needs.&#8221;
Also Read: <a target="_blank" href="https://www.benzinga.com//node/40909973" rel="noreferrer noopener">BlackRock, Microsoft, Others Team Up For $30B Artificial Intelligence Fund: Help US Fuel &#8216;AI Innovation And Economic Growth&#8217;</a>
U.S. Congressman Scott Perry said, &#8220;This critical step forward will ensure Pennsylvania has sufficient baseload power to meet its needs for decades to come while producing 3,400 jobs in our community.&#8221;
Investors can gain exposure to the stock via&nbsp;Strive Natural Resources and Security ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTWO#NYSE">FTWO</a>) and Virtus Reaves Utilities ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UTES#NYSE">UTES</a>).
Price Action: CEG shares are up 12.1% at $233.80 premarket at the last check Friday.
Photo by metamorworks via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40823561/this-under-the-radar-defensive-ai-sector-quietly-outperforms-all-others-despite-rec" target="_blank" rel="noreferrer noopener">This Under-The-Radar Defensive AI Sector Quietly Outperforms All Others, Despite Receiving &#8216;No Love&#8217; From Investors</a></li>
</ul>

FTWO

MSFT

UTES

Microsoft Taps Constellation For 20-Year Carbon-Free Power – 3,400 Jobs Coming To Pennsylvania

Morgan Stanley analyst Brian Harbour maintains Darden Restaurants (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) with a Overweight and raises the price target from $175 to $188.

Morgan Stanley Maintains Overweight on Darden Restaurants, Raises Price Target to $188

Wells Fargo analyst Colin Langan upgrades Aptiv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>) from Equal-Weight to Overweight and raises the price target from $78 to $87.

APTV

Wells Fargo Upgrades Aptiv to Overweight, Raises Price Target to $87

In the latest trading session, Crocs (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crox#NASDAQ">CROX</a>) closed at $137.92, marking a -1.35% move from the previous day. The stock&#39;s performance was behind the S&amp;P 500&#39;s daily gain of 1.7%. Meanwhile, the Dow experienced a rise of 1.26%, and the technology-dominated Nasdaq saw an increase of 2.51%.
Coming into today, shares of the footwear company had lost 0.56% in the past month. In that same time, the Consumer Discretionary sector gained 2.85%, while the S&amp;P 500 gained 1.27%.
The investment community will be closely monitoring the performance of Crocs in its forthcoming earnings report. The company&#39;s earnings per share are projected to be $3.11, reflecting a 4.31% decrease from the same quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $1.05 billion, indicating a 0.08% increase compared to the same quarter of the previous year.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $12.85 per share and revenue of $4.12 billion, indicating changes of +6.82% and +4%, respectively, compared to the previous year.
Furthermore, it would be beneficial for investors to monitor any recent shifts in analyst projections for Crocs. These revisions typically reflect the latest short-term business trends, which can change frequently. Therefore, positive revisions in estimates convey analysts&#39; confidence in the company&#39;s business performance and profit potential.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.11% higher. As of now, Crocs holds a Zacks Rank of #2 (Buy).
In terms of valuation, Crocs is currently trading at a Forward P/E ratio of 10.88. This denotes a discount relative to the industry&#39;s average Forward P/E of 19.27.
We can also see that CROX currently has a PEG ratio of 1.4. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company&#39;s projected earnings growth. The Textile - Apparel industry currently had an average PEG ratio of 2.01 as of yesterday&#39;s close.
The Textile - Apparel industry is part of the Consumer Discretionary sector. At present, this industry carries a Zacks Industry Rank of 171, placing it within the bottom 33% of over 250 industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
<a href="https://www.zacks.com/stock/news/2338839/crocs-crox-stock-drops-despite-market-gains-important-facts-to-note?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_6v2-2338839">To read this article on Zacks.com click here.</a>

Mid Cap

CROX

Crocs Stock Drops Despite Market Gains: Important Facts to Note

RBRK

Rubrik Expands Cyber Recovery And Incident Response Capabilities For Nutanix AHV, Offering Enhanced Testing, Recovery Validation, And Forensic Investigation Tools

Loop Capital analyst Alton Stump reiterates Domino's Pizza (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>) with a Hold and maintains $419 price target.

Reiteration

Loop Capital Reiterates Hold on Domino's Pizza, Maintains $419 Price Target

Crypto
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40955750/bitcoins-correction-ends-but-it-has-to-break-this-target-to-surge-to-70k-10x-research">Bitcoin&#8217;s Correction Ends, But It Has To Break This Target To Surge To $70K: 10x Research</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40954186/fbi-arrests-2-people-allegedly-behind-230m-bitcoin-heist-laundered-proceeds-were-spent-on-">FBI Arrests 2 People Allegedly Behind $230M Bitcoin Heist: Laundered Proceeds Were Spent On Globetrotting, High-End Wheels, And Designer Handbags</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40951537/solana-based-memecoins-spike-dogwifhat-bonk-outshine-dogecoin-shiba-inu-in-24-hour-gains">Solana-Based Memecoins Spike — Dogwifhat, Bonk Outshine Dogecoin, Shiba Inu In 24-Hour Gains</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40951091/bitcoin-ethereum-dogecoin-move-higher-as-aggressive-rate-cut-by-fed-fuels-crypto-demand-to">Bitcoin, Ethereum, Dogecoin Move Higher As Aggressive Rate Cut By Fed Fuels Crypto Demand: Top Trader&#8217;s Bullish Forecast For King Crypto Hinges On This Condition</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40950912/bitcoins-reserve-asset-appeal-increased-due-to-state-of-us-federal-deficit-and-debt-says-b">Bitcoin&#8217;s Reserve Asset Appeal Increased Due To State Of US Federal Deficit And Debt, Says BlackRock: A Hedge Against &#8216;Possible Future Events&#8217; Affecting The Dollar</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40956111/pepe-leapfrogs-dogecoin-shiba-inu-in-30-day-gains-trading-volume-no-one-is-bullish-enough-">Pepe Leapfrogs Dogecoin, Shiba Inu In 30-Day Gains, Trading Volume: &#8216;No One Is Bullish Enough,&#8217; Says Trader</a></li>
</ul>
US Politics
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40956172/trump-vs-harris-will-warren-buffett-display-a-blue-or-red-dot-in-his-front-yard-neighbors-wait-to-se">Trump Vs. Harris: Will Warren Buffett Display A Blue Or Red Dot In His Front Yard? Neighbors Wait To See Who The Oracle Of Omaha Is Supporting</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40953535/anybody-who-votes-for-a-democrat-or-kamala-worst-you-should-have-your-head-examined-trump-tells-vote">&#8216;Anybody Who Votes For A Democrat Or Kamala, Worst…You Should Have Your Head Examined:&#8217; Trump Tells Voters In Washington As Poll Numbers Plummet</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40952944/anthony-scaramucci-says-trumps-3-legged-stool-strategy-of-racism-misogyny-and-anti-immigration-will">Anthony Scaramucci Says Trump&#8217;s 3-Legged Stool Strategy Of &#8216;Racism, Misogyny And Anti-Immigration&#8217; Will Misfire: Here&#8217;s What Would Seal The Deal For Kamala Harris</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40951090/kamala-harris-underlines-her-support-for-second-amendment-dismisses-false-dichotomy-of-gun-control-d">Kamala Harris Underlines Her Support For Second Amendment, Dismisses False Dichotomy Of Gun Control Debate: Jokes To Oprah: &#8216;If Somebody Breaks In My House They Getting Shot&#8217;</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40950764/kamala-harris-tells-oprah-winfrey-she-felt-a-sense-of-responsibility-after-bidens-sudden-exit-it-cam">Kamala Harris Tells Oprah Winfrey She Felt A &#8216;Sense Of Responsibility&#8217; After Biden&#8217;s Sudden Exit: It Came With A &#8216;Sense of Purpose&#8217;</a></li>
</ul>
US Markets­­­­­­­­
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40954521/wall-street-looks-to-pause-after-s-ps-record-performance-as-fed-rate-cut-euphoria-fades-and-hard-la">Wall Street Looks To Pause After S&amp;P&#8217;s Record Performance As Fed Rate-Cut Euphoria Fades And Hard-Landing Fears Surface</a></li>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40952252/nvidia-tesla-rally-as-dow-s-p-500-surge-to-fresh-highs-after-fed-cuts-rates-fear-index-remains-in-g">Nvidia, Tesla Rally As Dow, S&amp;P 500 Surge To Fresh Highs After Fed Cuts Rates: Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>
World Politics
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40955425/top-us-officials-skeptical-of-israel-hamas-cease-fire-and-hostage-deal-before-bidens-term-ends-repor">Top US Officials Skeptical Of Israel-Hamas Cease-Fire And Hostage Deal Before Biden&#8217;s Term Ends: Report</a></li>
<li><a href="https://www.benzinga.com/24/09/40954613/kim-jong-uns-show-of-force-with-missiles-indicates-north-korea-is-no-longer-interested-in-negotiatio">Kim Jong Un&#8217;s &#8216;Show Of Force&#8217; With Missiles Indicates North Korea Is No Longer Interested In Negotiations With US, Say Analysts</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40952025/us-keeps-missiles-vital-for-defence-of-taiwan-in-philippines-despite-beijings-demands-for-removal-re">US Keeps Missiles Vital For Defence Of Taiwan In Philippines Despite Beijing&#8217;s Demands For Removal: Report</a></li>
</ul>
US Economy
<ul>
<li><a href="https://www.benzinga.com/real-estate/24/09/40955378/mortgage-rates-drop-but-homebuyers-still-say-no-thanks-heres-whats-really-behind-the-buyer-strike">Mortgage Rates Drop, But Homebuyers Still Say &#8216;No Thanks&#8217;– Here&#8217;s What&#8217;s Really Behind The Buyer Strike</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40950904/claudia-sahm-underscores-feds-mandate-to-protect-jobs-says-additional-cuts-expected-the-time-to-supp">Claudia Sahm Underscores Fed&#8217;s Mandate to Protect Jobs, Says Additional Cuts Expected: &#8216;The Time To Support The Labor Market Is When It&#8217;s Strong&#8217;</a></li>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40955933/brace-for-stagflation-after-feds-benevolence-warns-analyst-raising-5-corporate-red-">Brace For Stagflation After Fed&#8217;s Benevolence, Warns Analyst, Raising 5 Corporate Red Flags: &#8216;Inflation Is Transitory Mistake All Over Again&#8217;</a></li>
</ul>
World Economy
<ul>
<li><a href="https://www.benzinga.com/markets/asia/24/09/40954672/asia-markets-advance-europe-edges-lower-and-gold-clocks-new-high-at-2-630-global-markets-overview">Asia Markets Advance, Europe Edges Lower And Gold Clocks New High At $2,630 – Global Markets Overview</a></li>
<li><a href="https://www.benzinga.com/markets/asia/24/09/40951221/bank-of-japan-leaves-interest-rate-at-0-25-diverging-from-feds-50-basis-point-cut">Bank Of Japan Leaves Interest Rate At 0.25%, Diverging From Fed&#8217;s 50 Basis Point Cut</a></li>
</ul>
Tech
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/09/40954565/amazon-extends-free-prime-membership-to-warehouse-workers-but-corporate-staff-left-out-ahea">Amazon Extends Free Prime Membership To Warehouse Workers, But Corporate Staff Left Out Ahead Of Holiday Rush</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40954193/salesforce-ceo-marc-benioff-slams-microsofts-copilot-compares-it-to-failed-clippy-assistant-like-wer">Salesforce CEO Marc Benioff Slams Microsoft&#8217;s Copilot, Compares It To Failed &#8216;Clippy&#8217; Assistant: &#8216;…Like We&#8217;re Selling Science Projects To Companies&#8217;</a></li>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40953906/huaweis-2-800-tri-fold-mate-xt-sparks-frustration-as-limited-stock-fails-to-meet-demand">Huawei&#8217;s $2,800 Tri-Fold Mate XT Sparks Frustration As Limited Stock Fails To Meet Demand</a></li>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40951144/tesla-nike-alibaba-fedex-trump-media-technology-why-these-5-stocks-are-on-investors-radars-today">Tesla, Nike, Alibaba, FedEx, Trump Media &amp; Technology: Why These 5 Stocks Are On Investors&#8217; Radars Today</a></li>
</ul>
Electric Vehicle
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40954673/rivian-introduces-100k-tri-max-variant-of-r1s-electric-suv-on-online-shop-which-can-go-from-0-60-mph">Rivian Introduces $100K Tri Max Variant Of R1S Electric SUV On Online Shop Which Can Go from 0-60 MPH In 3s</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40953641/alphabets-waymo-hyundai-in-talks-to-use-ioniq-5-suvs-as-robotaxis-report">Alphabet&#8217;s Waymo, Hyundai In Talks To Use Ioniq 5 SUVs As Robotaxis: Report</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40952233/gms-cruise-eyes-resuming-robotaxi-operations-in-california-after-long-pause-due-to-pedestrian-accide">GM&#8217;s Cruise Eyes Resuming Robotaxi Operations In California After Long Pause Due To Pedestrian Accident In 2023</a></li>
</ul>
Consumer
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40955424/gm-to-recall-nearly-450k-vehicles-over-inoperative-warning-lights-on-loss-of-brake-fluid">GM To Recall Nearly 450K Vehicles Over Inoperative Warning Lights On Loss Of Brake Fluid</a></li>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40955083/holiday-opportunity-macys-plans-to-hire-31-500-seasonal-workers">Holiday Opportunity: Macy&#8217;s Plans To Hire 31,500 Seasonal Workers</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40954074/why-nike-shares-are-trading-higher-by-around-7-here-are-20-stocks-moving-premarket">Why Nike Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket</a></li>
</ul>
Communication
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/09/40954271/netflix-boosts-its-burgeoning-game-library-with-civilization-vi-and-street-fighter-iv-and-y">Netflix Boosts Its Burgeoning Game Library With Civilization VI And Street Fighter IV, And You Can Play Them At No Extra Cost</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40953653/tesla-bull-pierre-ferragu-calls-elon-musks-x-update-revolutionary-urges-for-a-custom-x-browser-this">Tesla Bull Pierre Ferragu Calls Elon Musk&#8217;s X Update Revolutionary, Urges For A Custom X Browser: &#8216;This Is Wikipedia To The Power Of Infinity&#8217;</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40952310/elon-musks-x-fined-1m-a-day-by-brazils-supreme-court-for-defying-ban-on-platform-judge-says-part-of">Elon Musk&#8217;s X Fined $1M A Day By Brazil&#8217;s Supreme Court For Defying Ban On Platform: Judge Says Part Of Effort To &#8216;Clean Up The Internet&#8217;</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40951748/there-is-no-escaping-youtube-ads-even-after-hitting-the-pause-button-disgruntled-users-cry-foul-an-a">There Is No Escaping YouTube Ads Even After Hitting The Pause Button — Disgruntled Users Cry Foul: &#8216;An Absolute Trash Idea&#8217;</a></li>
</ul>
Healthcare
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/09/40956171/european-drug-agency-supports-novo-nordisks-blockbuster-weight-loss-drug-wegovy-for-obesity-relat">European Drug Agency Supports Novo Nordisk&#8217;s Blockbuster Weight-Loss Drug Wegovy For Obesity-Related Heart Failure</a></li>
</ul>
General
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40951997/palantir-co-founder-joe-lonsdale-backs-elon-musks-twitter-acquisition-saying-if-he-had-not-bought-it">Palantir Co-Founder Joe Lonsdale Backs Elon Musk&#8217;s Twitter Acquisition, Saying If He Had Not Bought It Then &#8216;The Entire West Would Be At 10x The Threat&#8217;</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40950634/the-secret-service-is-aware-of-the-social-media-post-made-by-elon-musk-says-law-enforcement-agency">&#8216;The Secret Service Is Aware Of The Social Media Post Made By Elon Musk,&#8217; Says Law Enforcement Agency</a></li>
</ul>
Space
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40951122/elon-musk-blasts-faa-for-targeting-spacex-over-petty-matters-while-ignoring-boeings-safety-issue">Elon Musk Blasts FAA For Targeting SpaceX Over &#8216;Petty Matters,&#8217; While Ignoring Boeing&#8217;s Safety Issues: This &#8216;Puts Human Lives At Risk&#8217;</a></li>
</ul>
Energy
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40954292/conocophillips-uniper-ink-10-year-gas-supply-deal">ConocoPhillips, Uniper Ink 10-Year Gas Supply Deal</a></li>
</ul>
Photo by Roy Buri via Pixabay

$BTC

$ETH

Bitcoin's Correction Ends, But Must Hit A Key Target To Reach $70K, Says 10x Research; European Drug Agency Backs Novo Nordisk's Wegovy For Obesity-Related Heart Failure - Top Headlines Today While US Slept

The Lovesac Company (LOVE – Research Report) received a Buy rating and price target from Craig-Hallum analyst Alex Fuhrman today. The company's sha...

The Lovesac Company (LOVE) Receives a New Rating from Craig-Hallum

D.A. Davidson analyst Michael Baker maintained a Buy rating on The Lovesac Company (LOVE – Research Report) today. The company's shares closed yest...

D.A. Davidson Sticks to Its Buy Rating for The Lovesac Company (LOVE)

The Lovesac Q2 2025 Earnings Preview

Here's the major earnings before the open tomorrow

The Lovesac GAAP EPS of -$0.38 beats by $0.06, revenue of $156.5M beats by $1.43M

Today, several major companies are expected to report earnings: Adobe (ADBE), Farmer Brothers Company (FARM), Kroger Company (KR), Signet Jewelers ...

Options Volatility and Implied Earnings Moves Today, September 12, 2024

Lovesac Q2 results beat expectations, offsetting mixed guidance

The Lovesac Company (LOVE) Q2 2025 Earnings Call Transcript

Canaccord Genuity analyst Maria Ripps has maintained their bullish stance on LOVE stock, giving a Buy rating yesterday. Maria Ripps has given her B...

Lovesac Company: A Buy Rating Amidst Solid Growth and Innovation

Roth MKM analyst Matt Koranda maintained a Buy rating on The Lovesac Company (LOVE – Research Report) today and set a price target of $31.00. The c...

Roth MKM Keeps Their Buy Rating on The Lovesac Company (LOVE)

ADBE

DOYU

FARM

RLGT

SBSW

Press Releases

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of The Lovesac Company (LOVE) Investigation

The Lovesac Company Announces a Five-Year Extension of Its Credit Facility and Inaugural Share Repurchase Program

The Lovesac Company Announces Second Quarter Conference Call Date

Lovesac Announces Limited-Edition Home Furnishings Collaboration with KidSuper

The Lovesac Company Reports Second Quarter Fiscal 2025 Financial Results

The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of The Lovesac Company – LOVE

Lovesac Introduces AnyTable, the First Fully Customizable Table Solution Designed to Transform Your Living Space

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Lovesac

Lovesac (LOVE) Forecast

Lovesac (NASDAQ:LOVE) Stock, Quote.Headers.trade-ideas